❗NEW CLINICAL TRIAL INVESTIGATION SITE❗ We are pleased to announce the addition of North Shore University Hospital in New York to our ReSPECT-LM Clinical Trial with Principal Investigator Michael Schulder, M.D.. This site is NOW ENROLLING patients. Michael Schulder, MD, is Professor and Vice Chair of the Department of Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, where he also serves as Program Director of Neurosurgical Residency training and Professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research at Northwell Health. He also is the Director of the Brain Tumor Center at the Northwell Neuroscience Institute. For more information about the ReSPECT-LM trial and how to contact Dr. Schulder’s patient coordinator, please visit: https://www.respect-trials.com/lm/
Recent Posts
- Transforming Radiation Therapy: Q&A with Plus Therapeutics CEO Dr. Marc Hedrick
- Refining Treatment for Leptomeningeal Metastases: ReSPECT-LM Trial Featured in Targeted Oncology
- Join Us Live: Dr. Andrew Brenner Talks ReSPECT Trials on Game On Glio’s Instagram
- Reshaping Neuro-Oncology with Targeted Radiotherapeutics: Q&A with Plus Therapeutics CEO Dr. Marc Hedrick
- Plus Therapeutics Receives $1.6 Million Advance Payment from CPRIT to Support ReSPECT-LM Trial for Leptomeningeal Cancer
Recent Comments